Sandrine Vessillier

Targeting cytokines to inflammation sites

Gill Adams, Sandrine Vessillier, Hanna Dreja et al. · Nature Biotechnology · 2003 · 65 citations

Inflammation, Cytokine, Allergy +7

Cytokine release assays for the prediction of therapeutic mAb safety in first-in man trials — Whole blood cytokine release assays are poorly predictive for TGN1412 cytokine storm

Sandrine Vessillier, David Eastwood, B. Fox et al. · Journal of Immunological Methods · 2015 · 63 citations · Full text

Inflammation, Therapeutic Mab Safety, Cytokine +15

Latent cytokines: development of novel cleavage sites and kinetic analysis of their differential sensitivity to MMP-1 and MMP-3

Sandrine Vessillier, Gail Adams, Yuti Chernajovsky · Protein Engineering Design and Selection · 2005 · 31 citations · Full text

Immunology, Immunologic Mechanism, Latent Cytokines +19

Hydrolysis of glycine‐containing elastin pentapeptides by LasA, a metalloelastase from <i>Pseudomonas aeruginosa</i>

Sandrine Vessillier, Frédéric Delolme, Jacques Bernillon et al. · European Journal of Biochemistry · 2001 · 30 citations · Full text

Cell therapy products: focus on issues with manufacturing and quality control of chimeric antigen receptor T‐cell therapies

Jim Eyles, Sandrine Vessillier, Anika Jones et al. · Journal of Chemical Technology & Biotechnology · 2018 · 30 citations · Full text

Cell Therapy, Immunology, Antigen Processing +19